Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 314 of 6351
-
Liver cancer trial aims to boost immunotherapy with targeted chemo
Disease control Not yet recruitingStudy Objectives: Atezolizumab (anti-programmed death-ligand 1; anti-PD-L1) combined with bevacizumab (anti-vascular endothelial growth factor; anti-VEGF) or Durvalumab (anti-programmed death-ligand 1; anti-PD-L1) combined with tremelimumab (anti-cytotoxic T-lymphocyte-associated…
Phase 2 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug combo could shorten histoplasmosis treatment by half
Disease control Not yet recruitingThe purpose of the study is threefold: 1. Assess the safety and efficacy of a single high-dose intravenous (LAmB 10mg/kg) compared to the SOC daily dosing (3mg/kg) of the same medication for induction therapy in moderate to severe histoplasmosis. 2. Assess the safety and efficac…
Phase 3 • Sponsor: University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Can a biomarker test unlock better treatment for Right-Sided colon cancer?
Disease control Not yet recruitingThe aim of this trial is to assess the feasibility of EREG/AREG assessment as a clinical diagnostic standard, used to guide clinical decision making in right-PTL, RAS-wt aCRC. Further to this, the aim is to determine whether EREG/AREG status identifies right-PTL participants who …
Phase 4 • Sponsor: Gruppo Oncologico del Nord-Ovest • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
New mRNA HIV vaccines enter early human testing
Vaccine Recruiting nowThis phase 1 study will evaluate the safety, tolerability, and immune responses of two experimental mRNA HIV vaccines in adults living with HIV who are in overall good health. The study will enroll about 42 participants at multiple study sites. Researchers will assess whether the…
Phase 1 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Vaccine
Last updated Aug 19, 2026 00:00 UTC
-
New hope for lymphoma: immune booster plus chemotherapy trial launches
Disease control Not yet recruitingA Phase II, open-label, two-arm, multicenter study evaluating the combination of epcoritamab with R-CHOP chemotherapy in patients with newly diagnosed, aggressive B-cell non-Hodgkin lymphoma.
Phase 2 • Sponsor: Carrie Ho, MD • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Flickering light and sound may shield young brains from Anesthesia's hidden risks
Disease control Not yet recruitingExposure to general anesthesia during early brain development has emerged as an important risk factor for long-term attention-deficit/hyperactivity disorder (ADHD)-like behaviors and learning difficulties in school-aged children. However, objective biomarkers for perioperative ne…
Phase 1 • Sponsor: General Hospital of Ningxia Medical University • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
Can a 6-Month class turn back frailty? a trial tests In-Person, online, and hybrid learning
Disease control Not yet recruitingThe goal of this clinical trial is to determine whether a 6-month healthy-aging education program delivered in person, online, or in a hybrid format reduces frailty and is cost-effective compared with usual care in community-dwelling adults aged 65 years or older with pre-frailty…
Sponsor: University of Cadiz • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a 9-Week online program lift depression in new dads?
Disease control Not yet recruitingThe purpose of the proposed study is to determine the effectiveness of an online, 9-week group cognitive behavioural therapy (CBT) intervention for paternal perinatal depression (PND) in fathers and fathers-to-be. Fathers or fathers-to-be living in Ontario, Canada who have depres…
Sponsor: McMaster University • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Can a smarter pacemaker lead protect the heart?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether left bundle branch area pacing, a technique designed to activate the heart's natural electrical conduction system, is better than conventional right ventricular pacing in adults with permanent atrial fibrillation, preserved hear…
Sponsor: Poitiers University Hospital • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Can an antibody clear the toxic clumps behind a rare brain disease?
Disease control Not yet recruitingMultiple system atrophy (MSA) is a progressive neurodegenerative disorder characterized by autonomic dysfunction, parkinsonism, and cerebellar ataxia. Abnormal aggregation of alpha-synuclein is believed to play an important role in disease progression. The α-Syn H21 monoclonal an…
Phase 1 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
Can a statin nanoparticle save sight in retinitis pigmentosa?
Disease control Not yet recruitingRetinitis pigmentosa (RP) is a rare inherited retinal degenerative disease that causes progressive visual field loss and vision impairment, often leading to blindness. Currently, there are limited treatment options capable of slowing disease progression for the majority of patien…
Phase 1 • Sponsor: Kyushu University • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
AI-Crafted care plan aims to stop a common ICU harm
Prevention Not yet recruitingMedical device-related pressure injuries (MDRPIs) are an important and largely preventable patient safety problem, particularly in intensive care units where the use of medical devices is frequent and prolonged. A recent meta-analysis reported an MDRPI incidence of approximately …
Sponsor: Koç University • Aim: Prevention
Last updated Aug 29, 2026 00:00 UTC
-
Can a smart oxygen device outperform manual care in recovery?
Disease control Not yet recruitingAcute hypoxemic respiratory failure (AHRF) is a common condition associated with substantial morbidity, mortality, and healthcare resource utilization. Although advances in oxygen therapy, particularly high-flow nasal oxygen (HFNO), have improved the management of AHRF, the trans…
Sponsor: Centre Hospitalier Universitaire de Besancon • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can virtual nature walks and laughter yoga calm Chemotherapy's toll?
Symptom relief Not yet recruitingAfter obtaining informed consent, pre-test applications will be performed on participants in the experimental and control groups following randomization, and information regarding treatment plans will be recorded. Patients in the experimental group will receive laughter yoga prac…
Sponsor: Ataturk University • Aim: Symptom relief
Last updated Sep 03, 2026 00:00 UTC
-
Can a pill quiet the adrenal Glands' hormone overdrive?
Disease control Not yet recruitingThe goal of this clinical trial is to find out whether treatment with baxdrostat changes aldosterone-producing activity in the adrenal glands of people with primary aldosteronism. The study will use specialised imaging to measure changes in the adrenal glands before and after tre…
Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
A brain stimulation trial aims to rewire the circuit behind depression
Disease control Not yet recruitingThe goal of this clinical trial is to learn how transcranial magnetic stimulation (TMS) affects brain circuits involving the subgenual anterior cingulate cortex (sgACC) in adults with depression. The main questions it aims to answer are: * Can brain responses in the sgACC before…
Early phase 1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Sep 10, 2026 02:00 UTC
-
Which Hands-On therapy eases sacroiliac pain better?
Disease control Not yet recruitingThis study, titled "Comparative Effects of Pelvic PNF and HVLA Thrust on Pain, Mobility, and Flexibility in Sacroiliac Joint Dysfunction," is a single-blinded randomized clinical trial (RCT) designed to evaluate and compare the therapeutic efficacy of two widely used but never di…
Sponsor: Ziauddin University • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a new vaccine shield adults from RSV?
Vaccine Not yet recruitingThis phase 1 study in China will evaluate the Safety and Preliminary Immunogenicity of Recombinant RSV Vaccine (CHO Cell) in Adults Aged 18 Years and Older
Phase 1 • Sponsor: Yikang Biotech (Suzhou) Co., Ltd. • Aim: Vaccine
Last updated Sep 10, 2026 00:00 UTC
-
A new MRI tracer might reveal if liver cancer treatment is working
Diagnosis Not yet recruitingThis proposal describes a non-therapeutic diagnostic clinical trial to estimate the ability of DNP-MRS imaging of hyperpolarized 1-13C-pyruvate uptake and metabolism to predict response following LRT with TACE/TARE/Microwave Ablation or ST in patients with Barcelona Clinic Liver …
Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Diagnosis
Last updated Sep 10, 2026 00:00 UTC
-
Can your own blood help stop leakage? a new trial investigates
Disease control Not yet recruitinghis prospective interventional study will evaluate the effectiveness and safety of peri-urethral injections of platelet-rich plasma for treating stress urinary incontinence in postmenopausal women. Platelet-rich plasma is prepared from each participant's own blood and contains co…
Sponsor: Benha University • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC